These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7881845)

  • 21. Questions on the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.
    Ringe JD
    Rheumatol Int; 2004 Nov; 24(6):370. PubMed ID: 15490174
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of corticosteroid-induced osteoporosis.
    Drug Ther Bull; 2010 Sep; 48(9):98-101. PubMed ID: 20810708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates.
    Ringe JD; Farahmand P
    Clin Rheumatol; 2007 Apr; 26(4):474-84. PubMed ID: 17122953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Corticosteroid-induced osteoporosis: epidemiology, physiopathology and clinical aspects].
    Sinigaglia L
    Reumatismo; 2006; 58 Spec No.1():49-54. PubMed ID: 23631062
    [No Abstract]   [Full Text] [Related]  

  • 25. Comments on 'Higher cumulative dose of topical corticosteroids is associated with osteoporosis and major osteoporotic fracture: A nationwide case-control study'.
    Chu WM; Ho HE; Wei JC
    J Eur Acad Dermatol Venereol; 2024 Sep; 38(9):e825-e826. PubMed ID: 38379366
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical practice guideline: drug therapy for corticosteroid-induced osteoporosis].
    Agence française de sécurité sanitaire des produits de santé
    Rev Mal Respir; 2004 Feb; 21(1):185-9. PubMed ID: 15260060
    [No Abstract]   [Full Text] [Related]  

  • 27. [Steroid induced osteoporosis: prevention and treatment].
    Roux C; Orcel P
    Rev Med Interne; 2003 Jun; 24(6):384-8. PubMed ID: 12814827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determining causation--a case study: adrenocorticosteroids and osteoporosis. Should the fear of inducing clinically important osteoporosis influence the decision to prescribe adrenocorticosteroids?
    Guyatt GH; Webber CE; Mewa AA; Sackett DL
    J Chronic Dis; 1984; 37(5):343-52. PubMed ID: 6371037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Corticosteroid-induced osteoporosis].
    Trombetti A; Pennisi P; Rizzoli R
    Rev Prat; 2004 Dec; 54(19):2132-7. PubMed ID: 15724591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and immunological improvement of myasthenia gravis following treatment with denosumab].
    Rodriguez-Gomez D; Gonzalez-Noya A; Marnotes-Gonzalez J; Lorenzo-Vizcaya AM
    Rev Neurol; 2017 Jan; 64(1):47-48. PubMed ID: 28000913
    [No Abstract]   [Full Text] [Related]  

  • 31. Zoledronic acid--once-yearly. Corticosteroid-induced osteoporosis: no benefit.
    Prescrire Int; 2010 Apr; 19(106):63. PubMed ID: 20568485
    [No Abstract]   [Full Text] [Related]  

  • 32. Does growth hormone treatment prevent corticosteroid-induced osteoporosis?
    Tanaka H; Seino Y
    Bone; 1996 Jun; 18(6):493-4. PubMed ID: 8805987
    [No Abstract]   [Full Text] [Related]  

  • 33. [Action of calcitonin in peri- and post-menopausal osteoporosis and in osteoporosis induced by long-term treatment with cortisone].
    Notario A; Bravi M; Torriani A; Broglia M; Giuffrè G; Gianoglio G
    Clin Ter; 1987 Oct; 123(2):95-103. PubMed ID: 2972477
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of corticosteroid-induced osteoporosis.
    Yeap SS; Hosking DJ
    Rheumatology (Oxford); 2002 Oct; 41(10):1088-94. PubMed ID: 12364625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bisphosphonate therapy in corticoid-induced osteoporosis].
    Ringe JD
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1231. PubMed ID: 9378048
    [No Abstract]   [Full Text] [Related]  

  • 36. High-dose corticosteroid exposure and osteoporosis intervention in adults.
    Che M; Ettinger B; Nguyen MT; Pressman AR; Johnston J
    Ann Allergy Asthma Immunol; 2006 Oct; 97(4):497-501. PubMed ID: 17069105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.
    Healey JH; Paget SA; Williams-Russo P; Szatrowski TP; Schneider R; Spiera H; Mitnick H; Ales K; Schwartzberg P
    Calcif Tissue Int; 1996 Feb; 58(2):73-80. PubMed ID: 8998681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticosteroid induced osteoporosis.
    Sambrook PN
    J Rheumatol Suppl; 1996 Aug; 45():19-22. PubMed ID: 8856647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticosteroid-induced osteoporosis.
    Lucasey B
    Nurs Clin North Am; 2001 Sep; 36(3):455-66, ix. PubMed ID: 11532660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis.
    Homik JE; Cranney A; Shea B; Tugwell P; Wells G; Adachi JD; Suarez-Almazor ME
    J Rheumatol; 1999 May; 26(5):1148-57. PubMed ID: 10332982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.